Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?-Reference-Cited by-同舟云学术

Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?

Published:2016-09-24 Issue:1 Volume:140 Page:234-246
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Synnott N.C.¹^ORCID,Murray A.¹,McGowan P.M.¹,Kiely M.²,Kiely P.A.²,O'Donovan N.³,O'Connor D.P.⁴,Gallagher W.M.⁵,Crown J.⁶,Duffy M.J.¹⁷

Affiliation:

1. UCD School of Medicine and Medical Science; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin; Dublin Ireland

2. Department of Life Sciences; University of Limerick; Limerick Ireland

3. National Institute for Cellular Biotechnology (NICB), Dublin City University; Dublin Ireland

4. Department of Molecular & Cellular Therapeutics; Royal College of Surgeons Ireland; Dublin Ireland

5. UCD School of Biomolecular and Biomedical Science; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin; Dublin Ireland

6. Department of Medical Oncology; St Vincent's University Hospital; Dublin Ireland

7. UCD Clinical Research Centre, St. Vincent's University Hospital; Dublin Ireland

Funder

Science Foundation Ireland, Strategic Research Cluster Award to Molecular Therapeutics for Cancer Ireland (MTCI)

The Clinical Cancer Research Trust, Eisai Co Ltd.

Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT

Irish Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. New strategies for triple-negative breast cancer-deciphering the heterogeneity;Mayer;Clin Cancer Res,2014

2. Targeted therapy for triple-negative breast cancer: where are we?;Duffy;Int J Cancer,2012

3. The management of early-stage and metastatic triple-negative breast cancer: a review;Anders;Hematol Oncol Clin North Am,2013

4. Comprehensive molecular portraits of human breast tumours;Cancer Genome Atlas Network;Nature,2012

5. The clonal and mutational evolution spectrum of primary triple-negative breast cancers;Shah;Nature,2012

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review;Medical Oncology;2024-08-09

2. Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer;Translational Oncology;2024-08

3. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A;Cancer Letters;2024-08

4. Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer;Cancer Medicine;2024-07

5. miR‐449a: A Promising Biomarker and Therapeutic Target in Cancer and Other Diseases;Cell Biochemistry and Biophysics;2024-05-29